SiliconIndia
Biocon Biologics Receives EMA Approval to Manufacture Bevacizumab in India
Team siliconindiaBiocon Biologics, a subsidiary of Biocon, received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab in India. This ...
17 hours ago
CNBC Awaaz
Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant
5 days ago
Livemint
Dividend Stocks: M&M, Piramal Ent, Tata Power, among others to trade ex-dividend next week; Check full list here | Stock Market News
13 minutes ago
The Economic Times
Biocon mAns facility approved by EMA to manufacture cancer drug in India - ET HealthWorld | Pharma
Biocon gets 4 observations from USFDA for Andhra facility - ET HealthWorld | Pharma
6 days ago
MC Inside Edge: Operators gear up for second innings in GNFC, Biocon finds new believers, broker hardsells airport play
1 day ago
View all
An Indian biopharmaceutical company
biocon.com
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. Wikipedia
Stock price: BIOCON.BO (BSE) ₹351.00 +4.85 (+1.40%)
Fri, Jun 28, 2024, 6:00AM EDT